Who Paid My Doc
Gabriel Valerio
Cornea and External Diseases Specialist San Diego, CA Medical Doctor
NPI 1598052524 CMS profile 4225306
34800 Bob Wilson Dr, San Diego, CA 92134
General payments
$935
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$125,000
Through program year 2025, Gabriel Valerio of San Diego, CA is reported in the CMS Open Payments database as having received $935 across 18 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $125,000 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 31st percentile of Cornea and External Diseases Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $246 | 5 | |
| 2024 | General | $18 | 1 | |
| 2023 | General | $133 | 4 | |
| 2022 | General | $229 | 5 | |
| 2021 | General | $23 | 1 | |
| 2020 | General | $164 | 1 | |
| 2019 | General | $122 | 1 |
Beside peers
- Gabriel Valerio
- Cornea and External Diseases Specialist median
- Middle half of Cornea and External Diseases Specialist
- National median
In program year 2025, general payments to Gabriel Valerio were reported at $246. Among 290 Cornea and External Diseases Specialist profiles paid that year, the median was $477 and the middle half received between $193 and $1,174.
Show as a table
| Year | Gabriel Valerio | Cornea and External Diseases Specialist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $122 | $276 | $111–$734 | $163 |
| 2020 | $164 | $146 | $48–$330 | $114 |
| 2021 | $23 | $254 | $116–$566 | $132 |
| 2022 | $229 | $251 | $106–$729 | $149 |
| 2023 | $133 | $344 | $149–$759 | $160 |
| 2024 | $18 | $366 | $170–$927 | $164 |
| 2025 | $246 | $477 | $193–$1,174 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
18 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cornea and External Diseases Specialist in California
Sumit Garg
Cornea and External Diseases Specialist · Irvine, CA
Jillian Chong
Cornea and External Diseases Specialist · Beverly Hills, CA
Tyson Kim
Cornea and External Diseases Specialist · San Francisco, CA
Edward Manche
Cornea and External Diseases Specialist · Stanford, CA
Michael Savetsky
Cornea and External Diseases Specialist · Culver City, CA
Michael Saidel
Cornea and External Diseases Specialist · Sonoma, CA
Related records
Cornea and External Diseases Specialist in California
Practitioners in the same specialty and state, ranked by reported value.
All Cornea and External Diseases Specialist
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.